Hologic investor relations material

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. The company offers technologies for mammography, 3D breast tomosynthesis (MammoSite(TM)), and FDA-cleared digital breast tomosynthesis (3D mammography); gynecologic imaging systems; and instruments for gynecology procedures; as well as software for diagnostic oncology centers and breast imaging. It also provides surgical services to support pre-, intra-, and postoperative care by surgeons or oncologists; preoperative planning tools for tumor management; and pathology review tools. In addition, the company offers facial aesthetics products comprising of injection devices designed to enhance aesthetics in patients undergoing anti-aging or cosmetic treatments such as neuromodulators that are used to smooth wrinkles and fine lines around the eyes.